Cannabinoids and Their Use for Chronic Pain – Cannabinoids as an Alternative to Opioids for Chronic Pain
[1]
Jessica Coleman, Department of Internal Medicine, Ochsner Clinical School, University of Queensland, New Orleans, USA.
Cannabinoids, Chronic Pain, Analgesics, Opioids
[1]
Haroutounian Simon, Ratz Yael, Ginosar Yehuda, et al. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-Label Study. The Clinical Journal of Pain. Volume 32 (12), December 2016, p 1036–1043. 10.1097/AJP.0000000000000364.
[2]
Kroenke, Kurt, MD; Cheville, Andrew, MD. Management of Chronic Pain in the Aftermarth of the Opioid Backlash. JAMA. 2017; 317 (23): 2365-2366. Doi: 10.1001/jama.2017.4884.
[3]
Philippe Lucas. Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain. Journal of Psychoactive Drugs Volume 44, 2012. 08 June 2012. http://dx.doi.org/10.1080/02791072.2012.684624
[4]
Beal, Benjamin; Wallace, Mark. An Overview of Pharmacologic Management of Chronic Pain. Medical Clinics of North America, 2016-01-01, Volume 100, Issue 1.
[5]
Wilsey Barth, Marcotte Thomas, Deutsch Reena. Low-Dose Vaporised Cannabis Significantly Improves Neuropathic Pain. The Journal of Pain. Volume 14, Issue 2. Feb 2013. http://www.sciencedirect.com/science/article/pii/S1526590012008644
[6]
Andreae Michael H, Carter George M, Shaparin Naum, et all. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta Analysis of Individual Patient Data. The Journal of Pain. Volume 16 Issue 12. December 2015. https://doi.org/10.1016/j.jpain.2015.07.009
[7]
Lee Michael, Ploner Markus, Wiech Katja. Amygdala activity contributes to the dissociative effect of cannabis on pain perception. PAIN Volume 154, issue 1, Jan 2013. https://doi.org/10.1016/j.pain.2012.09.017
[8]
Berengere Houze, Hejar El-Khatib, Caroline Arbour. Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches. Progress in Neuro Psychopharmacology and Biological Psychiatry. Volume 79, Part B. 3 October 2017. https://doi.org/10.1016/j.pnpbp.2017.06.035
[9]
Blake Alexia, Wan Bo Angela, Malek Leila. A selective review of medical cannabis in cancer pain management. Annals of Palliative Medicine. http://apm.amegroups.com/article/view/16199. 2017.
[10]
Grotenhermen F, Müller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 2012; 109: 495-501.
[11]
Kahan Meldon, Srivastasva Anita, Spithoff Sheryl, Bromley Lisa. Prescribing smoked cannabis for chronic noncancer pain. Canadian Family Physician December 2014, 60 (12) 1083-1090.
[12]
Andresen SR, Biering-Sorensen F, Hagen EM, et al. Cannabis use in persons with traumatic spinal cord injury in Denmark. J Rehabil Med. 2017 Jan 31; 49 (2): 152-160. doi: 10.2340/16501977-2105.
[13]
Hasandeep Singh, Sakshi Bhushan, Rohit Arora, et al. Alternative treatment strategies for neuropathic pain: Role of Indian medicinal plants and compounds of plant origin-A review. Biomedicine & Pharmacotherapy. Volume 92, August 2017. https://doi.org/10.1016/j.biopha.2017.05.079
[14]
Lin LA, Bohnert ASB, Jannausch M, et al. Use of non-pharmacological strategies for pain relief in addiction treatment patients with chronic pain. American Journal on Addictions 2017 26: 6 (564-567).
[15]
Knishkowy, Barry. Medical cannabis for pain in adolescence. Journal of Pain Management, suppl. Special Issue: Cannabis; Hauppauge 9.4 (2016): 415-421.
[16]
Fitzcharles M. A., Baerwald C, Albin J. Efficacy tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome and rheumatoid arthritis): A systematic review of randomised controlled trials. Schmerz 2016 30: 1 (47-61)
[17]
Zajicek JP, Hobart, JC, Slade A, et al. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. 2012 Nov; 83 (11): 1125-32. doi: 10.1136/jnnp-2012-302468. Epub 2012 Jul 12.
[18]
Kral AH, Wenger L, Novak SP, et al. Is cannabis use associated with less opioid use among people who inject drugs? Drug Alcohol Depend. 2015 Aug 1; 153: 236-41. doi: 10.1016/j.drugalcdep.2015.05.014. Epub 2015 May 22.
[19]
Goldenberg Matthew, Reid Mark, IsHak Waguih. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug and Alcohol Dependence. Volume 174, 1 May 2017. https://doi.org/10.1016/j.drugalcdep.2016.12.030
[20]
Boehnke Kevin, Litinas Evangelos, Clauw Daniel. Medical Cannabis Use is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. The Journal of Pain. Volume 17, issue 6, June 2016. https://doi.org/10.1016/j.jpain.2016.03.002.
[21]
Ware Mark, Wang Tongton, Shapiro Stan, et al. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). The Journal of Pain, Volume 16, Issue 12, December 2015. https://doi.org/10.1016/j.jpain.2015.07.014
[22]
Khaiser Minhaz, Peng Meiko, Ahrari Soha. Medical Cannabis dosing strategies in pain-related conditions: A scoping review of current literature. Journal of Pain Management, suppl. Special Issue: Cannabis; Hauppauge 9.4 (2016): 449-463.
[23]
Temple Leslie. Medical marijuana and pain management. Disease-a-Month, Volume 62, Issue 9. September 2016. https://doi.org/10.1016/j.disamonth.2016.05.014
[24]
Adverse effects of cannabis. Prescrire Int. 2011 Jan; 20 (112): 18-23. PMID: 21462790
[25]
Klugman A, Gruzelier J. Chronic cognitive impairment in users of “ecstasy” and cannabis. World Psychiatry. 2003; 2 (3): 184-190.
[26]
Rabner J, Gottlieb S, Lazdowsky L, et al. Psychosis following traumatic brain injury and cannabis use in late adolescence. Am J Addict. 2016 Mar; 25 (2): 91-3. doi: 10.1111/ajad.12338. Epub 2016 Feb 5.
[27]
Shah Arya, Craner Julia, Cunningham Julie. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes. Journal of Substance Abuse Treatment. Volume 77, June 2017. https://doi.org/10.1016/j.jsat.2017.03.012
[28]
Burnett Amy. The Adverse effects of cannabis use in adolescents. Journal of Pain Management, suppl. Special Issue: Cannabis; Hauppauge 9. 4 (2016): 423-425.
[29]
Blanco C, Ogburn E, de los Cobos JP, et al. DSM-IV criteria-based clinical subtypes of cannabis use disorders: Results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Drug and alcohol dependence. 2008; 96 (0): 10.1016/j.drugalcdep.2008.02.008. doi: 10.1016/j.drugalcdep.2008.02.008.
[30]
Desjardins N, Jamoulle O, Taddeo D, Stheneur C. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent. J Adolesc Health. 2015 Nov; 57 (5): 565-7. doi: 10.1016/j.jadohealth.2015.07.019. Epub 2015 Sep 12.